JP2024537234A5 - - Google Patents
Info
- Publication number
- JP2024537234A5 JP2024537234A5 JP2024521130A JP2024521130A JP2024537234A5 JP 2024537234 A5 JP2024537234 A5 JP 2024537234A5 JP 2024521130 A JP2024521130 A JP 2024521130A JP 2024521130 A JP2024521130 A JP 2024521130A JP 2024537234 A5 JP2024537234 A5 JP 2024537234A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- substitution
- tgf
- monomer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163254249P | 2021-10-11 | 2021-10-11 | |
| US63/254,249 | 2021-10-11 | ||
| PCT/US2022/077879 WO2023064747A1 (en) | 2021-10-11 | 2022-10-11 | Engineered tgf-beta monomers and methods of use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024537234A JP2024537234A (ja) | 2024-10-10 |
| JP2024537234A5 true JP2024537234A5 (enExample) | 2025-10-10 |
Family
ID=85988028
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024521130A Pending JP2024537234A (ja) | 2021-10-11 | 2022-10-11 | 操作されたＴＧＦ－βモノマーおよび使用法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240425559A1 (enExample) |
| EP (1) | EP4416172A4 (enExample) |
| JP (1) | JP2024537234A (enExample) |
| KR (1) | KR20240082356A (enExample) |
| CN (1) | CN118103390A (enExample) |
| AU (1) | AU2022367394B2 (enExample) |
| CA (1) | CA3232809A1 (enExample) |
| TW (1) | TW202330579A (enExample) |
| WO (1) | WO2023064747A1 (enExample) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW517059B (en) * | 1994-07-25 | 2003-01-11 | Ciba Geigy Ag | New process for the production of biologically active protein |
| US11091523B2 (en) * | 2016-11-18 | 2021-08-17 | University of Pittsburgh—of the Commonwealth System of Higher Education | Engineered TGF-β monomers and their use for inhibiting TGF-β signaling |
| JP2023539195A (ja) * | 2020-08-27 | 2023-09-13 | ユニバーシティ オブ ピッツバーグ － オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション | 組換えトランスフォーミング増殖因子（ｔｇｆ）－ベータ単量体をコードする腫瘍溶解性ウイルスおよびその使用 |
-
2022
- 2022-10-11 WO PCT/US2022/077879 patent/WO2023064747A1/en not_active Ceased
- 2022-10-11 CA CA3232809A patent/CA3232809A1/en active Pending
- 2022-10-11 TW TW111138471A patent/TW202330579A/zh unknown
- 2022-10-11 US US18/700,446 patent/US20240425559A1/en active Pending
- 2022-10-11 KR KR1020247012779A patent/KR20240082356A/ko active Pending
- 2022-10-11 JP JP2024521130A patent/JP2024537234A/ja active Pending
- 2022-10-11 EP EP22881943.9A patent/EP4416172A4/en active Pending
- 2022-10-11 AU AU2022367394A patent/AU2022367394B2/en active Active
- 2022-10-11 CN CN202280068897.4A patent/CN118103390A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2576615B1 (en) | Fibronectin based scaffold proteins having improved stability | |
| JP2020500511A5 (enExample) | ||
| US11952432B2 (en) | Cell-permeable stapled peptide modules for cellular delivery | |
| JP7045333B2 (ja) | 操作されたＦｃコンストラクトに関する組成物及び方法 | |
| JP4398644B2 (ja) | ＥｒｂＢ界面ペプチド擬態およびその使用方法 | |
| CN113166220A (zh) | 创新细胞因子前药 | |
| CN102007145A (zh) | 基于结合egfr的工程化蛋白质的靶向治疗剂 | |
| CN114269366A (zh) | 重组fap结合蛋白及其用途 | |
| JP2023036899A5 (enExample) | ||
| ES3011833T3 (en) | Engineered tgf-beta monomers and their use for inhibiting tgf-beta signaling | |
| JP2015535523A (ja) | アプロチニン由来ポリペプチド−抗体コンジュゲート | |
| JP2022191261A (ja) | 操作されたＦｃコンストラクトに関する組成物及び方法 | |
| KR101687060B1 (ko) | 모에신 조절제 및 그의 용도 | |
| JP2021522795A5 (enExample) | ||
| US20230090247A1 (en) | Molecules targeting ras protein | |
| JP2024537234A5 (enExample) | ||
| US10308917B2 (en) | Nucleotide sequences encoding VEGF antagonist compositions of FLT-1 and uses thereof | |
| JP2021522793A5 (enExample) | ||
| JP2023548345A (ja) | クリッピング率の低減した抗原結合ドメイン | |
| CN116917339A (zh) | 靶向dr4和/或dr5的多肽以及相关组合物和方法 | |
| EP4559932A1 (en) | Multispecific antibody and use thereof | |
| EP4512826A2 (en) | Dimeric protein complexes and uses thereof | |
| JP2025531328A (ja) | キメラ抗原受容体ｔ細胞の可逆的制御 | |
| CN111511917A (zh) | 肽结合物 | |
| CA3242904A1 (en) | VEGF-BINDING AND TIE2 FUSION PROTEIN AND ITS USES |